✨ Excited to share I've been awarded an ERC Starting Grant! ✨
🧬 We'll study how mutated hematopoietic cells evolve & interact with other cells, including tumor cells.
🙏 Grateful to all colleagues & mentors for their support!
🚀 Positions coming soon!
@gustaveroussy.fr @gr-research.bsky.social
05.09.2025 07:47 — 👍 9 🔁 0 💬 1 📌 0
Cutting-edge research in immunology from around the world, and commentaries by thought leaders. Cell Press. Tweets by Immunity editors.
Daring to solve some of the most complex challenges in cancer research | Founded by Cancer Research UK & The NCI
https://www.cancergrandchallenges.org/
Group Leader @ Early Cancer Institute, University of Cambridge | Research: clonal haematopoiesis, MDS, AML & blood cancer evolution 🩸🔬🧬 | Honorary Consultant Haematologist 🩺
Investigador ICREA @icreacommunity a @CarrerasIJC, Catedràtic Genètica @UniBarcelona, Director Programa #Epigenètica i Biologia del Càncer
Cancer Physician Scientist
@hebrewuniversity.bsky.social
@lautenbergc.bsky.social
@ims-mrl.bsky.social
Functional genomics.
Breast cancer ecosystems.
Cell state and cell fate.
Precision Cancer Medicine 2.0
#METABRIC
#DETECT
#TransNEO
#PDTXs
Genomics, LLMs, spatial cancer evo | Group leader @DanaFarber @Harvard | Head of Data Science at Hale Center for Pancreatic Cancer | PhD @eth
Head of preclinical pediatric cancer research @ChariteBerlin ECRC @MDC_Berlin. Extrachromosomal DNA (ecDNA) in cancer. Cancer Grand Challenges Team eDyNAmiC
Epigenetics | Cancer Biology | Professor and Chief Executive The Institute of Cancer Research
Somatic evolution in childhood cancer
Group leader @Prinses Máxima Center for Pediatric Oncology
and @Oncode Institute
Yale Dpt of Neurosurgery, cancer research, brain tumors, ecDNA, likes football, drums and karaoke.
Director of the Swiss Institute of Experimental Cancer Research- ISREC@EPFL, Associate Professor, in love with science and experiments
Assistant prof at Stanford. Interested in aneuploidy, mitotic kinases, cancer therapeutics, and drug development. Co-founder x2.
We use human organoid models to study the emergence and transformation of early-stage colorectal cancer.
We aim to prevent rather than cure.
Research lab at Prinses Maxima Center (formerly at UMC Utrecht) & Oncode Institute
VP for Research, T.H. Smoot Professor
Depts Chemical and Biomolecular Engn, Pathology, Oncology, INBT
Johns Hopkins University
3D multi-omic, CAR T therapy, cell migration and mechanics
Lab: https://wirtzlab.johnshopkins.edu
Researching somatic evolution at the University of Cambridge and Wellcome Sanger Institute. Also a scientific illustrator.
Team leader at CRUK National Biomarker Centre, University of Manchester.
https://cruknbc.org/research/nucleic-acids-biomarkers/
#liquidbiopsy #cfDNA #EV #multiomics
We work on minimal residual disease and metastasis by colorectal cancer from the perspective of cancer stem cells and their interaction with the tumor microenvironment.
@IRBBarcelona,bsky.social
Cancer programme Faculty @sangerinstitute.bsky.social & founder MosaicTx developing precision combination therapies. #Cancer, Functional genomics, biomarkers, target discovery, #organoid, #CRISPR. Proud 🇨🇦.
